NCT06803680 2026-04-15
A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors
BeOne Medicines
Phase 1 Recruiting
Clinical Trials
26 trialsNCT07498725 2026-03-27
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors
LARKSPUR BIOSCIENCES, INC.
Phase 1/2 Not yet recruiting
NCT06540066 2026-03-16
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
BeOne Medicines
Phase 1 Terminated
NCT05935098 2026-03-13
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
BeOne Medicines
Phase 1 Terminated
NCT05717166 2025-12-31
SABR-SYNC
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3 Recruiting
NCT01558544 2025-12-10
Cryopreservation of Ovarian Tissue
Weill Medical College of Cornell University
Phase NA Recruiting
NCT03721341 2025-09-18
SABR-COMET 10
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3 Active not recruiting
NCT06717178 2025-04-02
Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China
RenJi Hospital
Recruiting
NCT03873883 2024-09-19
IO-001
iTeos Therapeutics
Phase 1 Completed
NCT05599698 2024-05-14
Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer
Bnai Zion Medical Center
Phase NA Recruiting
NCT06238752 2024-02-02
RENMIN-213
Renmin Hospital of Wuhan University
Phase 2 Completed
NCT05237349 2024-01-05
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT05442177 2022-07-01
Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity
Taichung Tzu Chi Hospital
Completed
NCT05241132 2022-02-15
Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary
Shanghai Changzheng Hospital
Phase 2 Unknown
NCT00936156 2020-06-29
Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2 Completed
NCT03299452 2019-02-15
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
Haining Health-Coming Biotech Co., Ltd.
Phase 2 Unknown
NCT02620423 2018-09-13
Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Oncolytics Biotech
Phase 1 Completed
NCT02004262 2018-06-04
ECLIPSE
Aduro Biotech, Inc.
Phase 2 Completed
NCT03491033 2018-04-10
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
Yonsei University
Completed
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01858571 2017-01-25
Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies
All India Institute of Medical Sciences
Phase 3 Completed
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02283424 2014-11-05
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
Chinese PLA General Hospital
Phase 4 Unknown
NCT00707278 2014-10-31
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
University of Utah
Phase 1 Completed
NCT00894153 2012-04-09
p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown
NCT00902083 2012-04-09
rAd-p53
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 4 Unknown